The importance of dosage for naltrexone treatment in Hailey-Hailey disease
Chloé Grolleau, MD, MSc,
Emmanuelle Bourrat, MD,
Geoffroy Hickman, MD,
Martine Bagot, MD, PhD,
Antoine Petit, MD,
Laure Frumholtz, MD, MSc,
Charles Cassius, MD, MSc
Affiliations
Chloé Grolleau, MD, MSc
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France; Université de Paris, INSERM U976, Institut de recherche Saint-Louis, Paris, France; Correspondence to: Chloé Grolleau, MD, MSc, Department of Dermatology, Hôpital Saint Louis, 1 avenue Claude Vellefaux, Paris, 75010, France
Emmanuelle Bourrat, MD
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France
Geoffroy Hickman, MD
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France
Martine Bagot, MD, PhD
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France; Université de Paris, INSERM U976, Institut de recherche Saint-Louis, Paris, France
Antoine Petit, MD
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France
Laure Frumholtz, MD, MSc
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France
Charles Cassius, MD, MSc
Department of Dermatology, Hôpital Saint Louis, AP-HP, Paris, France; Université de Paris, INSERM U976, Institut de recherche Saint-Louis, Paris, France
